Most institutions including our own, are using chemotherapy based regimens such as targeted busulfan and cyclophosphamide, and are not using TBI prior to transplantation.
Similarly to testicular cancer, chemotherapy with cisplatin based regimens such as BEP and POMB-ACE can bring dramatic responses to treatment and cure is the most likely outcome even for patients with widespread metastatic disease [ 33].
A total of 131 patients (84.5%) received a thalidomide-based regimen, such as cyclophosphamide, thalidomide, and dexamethasone (CTD), melphalan, prednisolone, and thalidomide (MPT), and thalidomide and dexamethasone (TD).
All of the patients had progressed after at least one previous platinum-based regimen, such as cisplatin plus pemetrexed (8 patients), vinorelbin (5 patients) or irinotecan (1 patient), and carboplatin plus paclitaxel (8 patients), pemetrexed (11 patients), or gemcitabine (6 patients).
In that study, most patients were treated with gemcitabine-based regimens such as gemcitabine monotherapy or gemcitabine/S-1 therapy.
The costs of irinotecan-based regimens such as IRIS and FOLFIRI were lower than those of oxaliplatin-based regimens, such as FOLFOX, and regimens including molecular targeted agents, such as FOLFOX + Bev and FOLFIRI + Bev or Cet.
The costs of oxaliplatin-based regimens such as FOLFOX were higher than those of irinotecan-based regimens such as IRIS and FOLFIRI.
However, the report did not include the recent effective regimen such as FOLFIRINOX and Gemcitabine/Nab-Paclitaxel.
Suffers are frequently associated with a particular eating regimen such as veganism or rawfoodism.
Using a non-ACT regimen, such as AQ+SP, may be preferable for IPT, allowing ACT regimens to be reserved for treatment of symptomatic malaria.
